© ESVD and ACVD
Edited By: Aiden Foster
Impact Factor: 1.568
ISI Journal Citation Reports © Ranking: 2015: 29/138 (Veterinary Sciences); 31/61 (Dermatology)
Online ISSN: 1365-3164
Content of Author Guidelines:
Veterinary Dermatology is a bi-monthly, peer-reviewed, international journal which publishes papers on all aspects of the skin of mammals, birds, reptiles, amphibians and fish. Scientific research papers, clinical case reports and reviews covering the following aspects of dermatology will be considered for publication:
- Skin structure (anatomy, histology, ultrastructure)
- Skin function (physiology, biochemistry, pharmacology, immunology, genetics)
- Skin microbiology and parasitology
- Pathogenesis, diagnosis and treatment, including prophylaxis, of skin diseases
- New disease entities
Please carefully read the instructions below for details on the submission of manuscripts, the journal's requirements and standards as well as information concerning the procedure after a manuscript has been accepted for publication in Veterinary Dermatology. Authors are encouraged to visit the Blackwell Publishing Author Services site (http://authorservices.wiley.com) for further general information on the preparation and submission of articles and figures.
Veterinary Dermatology adheres to ethical guidelines given below for publication and research.
2.1. Authorship and Acknowledgements
Veterinary Dermatology adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). According to the ICMJE criteria authorship should be based on:
- Substantial contributions to conception and design of, or acquisition of data or analysis and interpretation of data, and
- drafting the article or revising it critically for important intellectual content and
- final approval of the version to be published.
All of the authors should meet conditions 1, 2 and 3.
Participation solely in the acquisition of funding or the collection of data (such as recruiting cases in multi-centre drug trials) does not justify authorship and, except in the case of complex large-scale or multi-centre research, the number of authors should usually not exceed six. It is a requirement that all authors have been accredited as appropriate upon submission of the manuscript. Contributors who do not qualify as authors should be mentioned under Acknowledgements, e.g. statisticians hired to analyse data; this may also include clinicians who recruit cases for multi-centre clinical trials.
Note to NIH Grantees: Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www.wiley.com/go/nihmandate
2.2. Ethical Approvals
When experimental animals are used the methods section must clearly indicate that adequate measures were taken to minimize pain or discomfort. Experiments should be carried out in accordance with the Guidelines laid down by the National Institute of Health (NIH) in the USA regarding the care and use of animals for experimental procedures or with the European Communities Council Directive of 24 November 1986 (86/609/EEC) and in accordance with local laws and regulations.
The Journal reserves the right to reject any paper where there is reason to believe that animals have been subjected to unnecessary or avoidable pain or distress. Where animals have been used in a study, the relevant research ethical or animal welfare or institutional review authority, under which the work was conducted, must be stated. Furthermore, manuscripts describing prospective studies involving client-owned animals should also include documentation of informed client consent.
2.3 Clinical Trials
Randomised clinical trials (RCTs) and systematic reviews should be reported with due regard for the REFLECT guidelines available at http://www.reflect-statement.org/statement/.
2.4 DNA Sequences and Crystallographic Structure Determinations
Papers reporting protein or DNA sequences will not be accepted without a Genbank accession number. Other supporting data sets must be made available on the publication date from the authors directly.
2.5 Conflict of Interest and Source of Funding
Conflict of Interest: Authors are required to disclose any possible conflict of interest, this may include financial support including consultancies, speaker's fees; any gift, income, funding or other material benefit, unsolicited or otherwise, from a commercial company or individual, even if it was not restricted to the project described in the submission. If in doubt please ask the editor for guidance about declaring a possible conflict. If the author does not include a conflict of interest statement in the manuscript then the following statement will be included by default: 'No conflicts of interest have been declared'.
Sources of funding: sources of institutional, private and corporate financial support for the work within the manuscript must be fully acknowledged.
The “conflict of interest” and “sources of funding” statements should be included immediately before the abstract section of your manuscript.
2.6 Appeal of Decision
Authors who wish to appeal the reviewers' decision and/or comments on their submitted paper may do so by e-mailing the editor with a detailed explanation for why they find reasons to appeal the decision.
If the whole or part(s) of previously published illustrations are used, permission must be obtained from the copyright holder concerned. It is the author's responsibility to obtain these in writing and provide copies to the Publishers. Images that have been sold commercially should not be submitted for publication.
2.8 Copyright Assignment
Authors submitting a paper do so on the understanding that the work and its essential substance have not been published before and is not being considered for publication elsewhere. Presentation or publication of part or all of the data in, for instance, congress proceedings, should be clearly declared when the paper is submitted.
Upon acceptance of a paper, authors are required to assign copyright to the European Society of Veterinary Dermatology and the American College of Veterinary Dermatology. Assignment of Copyright is a condition of publication. (Papers subject to government or Crown copyright are exempt from this requirement; however, the form still has to be signed).
Correspondence to the journal is accepted on the understanding that the contributing author licences the publisher to publish the letter as part of the journal or separately from it, in the exercise of any subsidiary rights relating to the journal and its contents.
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:
CTA Terms and Conditions
For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.
For RCUK and Wellcome Trust authors click on the link above to preview the terms and conditions of this license.
For questions concerning copyright, please visit Copyright FAQs.
2.9 Committee on Publication Ethics (COPE)
VDE is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).
Manuscripts should be submitted electronically via the online submission site http://mc.manuscriptcentral.com/vde.
If assistance is needed (or if, for some reason, online submission is not possible) the Editorial Office can be contacted at VDEedoffice@wiley.com and will readily provide any help users need to upload their manuscripts.
Papers are invited in the following categories: Reviews, Scientific Papers, Brief Communications, Case Reports, Letters to the Editor and Book Reviews (by invitation from the journal).
- Reviews are by invitation from the journal or with approval from the Editor in Chief.
- Scientific Papers are experimental or observational, ideally hypothesis-driven prospective studies.
- Brief Communications are brief reports and will be limited to 1500 words (based on the text and not counting the words in the title, abstract and references) and up to four figures or tables or graphs. References should be limited to ten.
For some articles the editor may require that the manuscript is reduced to less than 750 words; the editor will annotate the abstract to several key points.
- Case Reports (or case series) will be limited to 1500 words (based on the text and not counting the words in the title, abstract and references) and up to four figures; they will be considered for publication primarily if they add new and useful information for the discipline of veterinary dermatology; consideration will be given to:
a. Reports of new diseases or conditions, or variations on recently described diseases.
b. Reports of diseases that are of zoonotic importance or are highly contagious.
c. Reports that will make a significant change in how a disease is diagnosed or treated.
Supporting information containing additional text and figures may be allowed.
The editors may require that a case report is reduced to less than 750 words; the abstract will be reduced to several key points by the editor.
- Letters to the Editor: will be limited to 750 words, including references, and two (usually one) image / figure / table which may include one clinical image and one of histopathology; letters may cover a variety of topics and these may include but are not restricted to:
a. Briefly highlighting an issue with a previously published paper.
b. Seeking to generate discussion or awareness of a developing area.
- Books for review should be sent to the Veterinary Dermatology Editorial Office at:
Veterinary Dermatology, Wiley-Blackwell, 9600 Garsington Road, Oxford, OX4 2DQ, UK
Veterinary Dermatology operates a system of double-blinded review and the names of the authors will not be disclosed to the reviewers. Authors should therefore avoid including anything that could identify them within the text. This, for example, includes: the name of the institution at which the work was performed; initials of the authors; acknowledgements and names of institutions on illustrations, etc. To enable double-blinded review, contributors (including acknowledgements) should only be named on the title page or uploaded separately as a supplementary file, and not on the manuscript. Authors should also avoid statements that could identify them through references (e.g. instead of 'we have previously shown that black is white’, authors should write 'previous studies have shown that black is white').
The manuscript (including references and figure legends) must be A4 or 8.5 x 11 inch format with 2.5 cm margins, single-spaced typed (please do not submit double line spaced), align text left, 12 point font using sans serif typeface such as Helvetica (Swiss), Arial or Verdana style (please do not use Times New Roman). Each line and page of the manuscript text should be numbered consecutively from the title page.
Authors are requested to write with the minimum of formatting and NOT to write over previous versions, which may contain hidden formatting. Do not enhance text and tables with unnecessary formatting (e.g. small capitals, headers). Software programmes that automatically create endnotes and footnotes should not be used.
In general, review articles are only by invitation and by approval of the Editor in Chief. The structure will vary depending on content. Authors should study the format used in previous issues of the journal for further guidance. Authors wanting to submit a review article should contact the Editor in Chief (via VDEedoffice@wiley.com) with a brief description of the article and outline.
Scientific Papers and Brief Communications
Manuscripts should be arranged as follows: title; acknowledgements; abstract; text with subdivisions as given below; references; legends for illustrations.
These are usually a chronological description of the case describing the history, physical findings, differential diagnoses, diagnostic tests, specialist diagnostic procedures, diagnoses, treatments and outcome.
The title of the article should be concise but informative. Drug trade names will not be included in the title. The first name, middle initial(s), and last name of each author must be given. Professional affiliations of the authors at the time of the study should be indicated using the symbols *, †, ‡, §, ¶, then **, †† etc., in this order; these are not superscripts. Titles (e.g. professor) and qualifications (e.g. DipACVD) are not required.
Please provide full address details for all of the authors. If an author's affiliation has changed since the study was performed, the author's new affiliation should be identified. The name of the corresponding author, any conflicts of interest and sources of funding (see section 2.5) should be stated. If information in the text has been presented at a scientific meeting, this should be indicated. A short running title of no more than 40 characters (counting letters and spaces) should also be included. The short running title will be used in the journal at the top of the page, see current publications. Keywords are NOT required.
The abstract should be no more than 250 words and must be constructed using the subheadings given below. While this format is most appropriate for scientific studies, the authors of reviews, brief communications and case reports are encouraged to also provide a structured abstract using the following:
- Background – A brief explanation of why the study was performed.
- Hypothesis/Objectives – A statement of the principal hypothesis tested in the study, a brief statement of the major objectives, or both.
- Animals – A concise description of the number of animals used in the study including the population from which they were drawn (e.g. research colony, hospital population) and any special characteristics of the animals (e.g. disease status).
- Methods – A statement of overall study design (e.g. randomized, blinded, placebo-controlled clinical trial; retrospective study) and principal interventions or methods.
- Reports of clinical trials should try to comply with the REFLECT guidelines http://www.reflect-statement.org/statement/.
State the purpose of the article. Summarize the rationale for the study or observation. Give only strictly pertinent references and do not review the subject extensively.
Materials and Methods
These should be described in sufficient detail to allow other workers to reproduce the results. References for study design and statistical methods should be to standard works (with pages stated) when possible rather than to papers where designs or methods were originally reported. Specify any statistics computer programs used. Report losses to observation (such as dropouts from a clinical trial).
The methods of data collection and use of statistical analysis will be checked by the referees, editors and, if necessary, a statistician. It is highly recommended that authors consult a professional statistician for advice on complex statistical analyses. It is also recommended that authors provide details of which statistical methods and the P-value, if relevant, have been used for each component of the data set (e.g. P = 0.08; ANOVA).
Drugs and therapeutic agents should be given in the format: drug ingredient (trade name; manufacturer name, city, (state), country), e.g. fenbendazole (Panacur; Intervet-Schering Plough, Milton Keynes, UK).
Drug names should follow the recommended International Non-Proprietary Names (rINN). Common examples include cefalexin, ciclosporin, meticillin and rifampicin.
Products such as equipment or methods should be given as: Product name (Company name; town or city, (state) and country); e.g. Datex CD 200-02 (Datex; Hatfield, UK); or SuperScript® III First-Strand Synthesis kit (Invitrogen, Carlsbad, CA, USA). The detailed information about drugs, therapeutic agents and products need only be given once.
Present your results in a logical sequence in the text, tables and illustrations. Do not repeat in the text data in the tables or illustrations. In manuscripts describing more than one animal, all animals should be assigned a case number.
The discussion should emphasize the new and important aspects of the study and the conclusions that follow from them. Include the implications of the findings and their limitations, including implications for future research. Relate the observations to other relevant studies. Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not completely supported by your data. Avoid claiming priority and alluding to work that has not been completed. State new hypotheses when warranted, but clearly indicate them as such.
Recommendations, when appropriate, may be included.
Acknowledgements (should be made on the title page or as a separate supplementary file and not included on the manuscript). These are to indicate support, advice or technical help that does not justify authorship. Please use first and second (family) names, e.g. The authors would like to thank Fred Flintstone for assistance with statistical analysis.
Funding sources should be included in the declared sources of funding (see section 2.5).
Language and style
The language of publication is English. Authors for whom English is a second language must have their manuscript thoroughly, and preferably professionally, edited by an English speaking person before submission to make sure that the English is of high quality. A list of independent suppliers of editing services can be found at http://authorservices.wiley.com/bauthor/english_language.asp. All services are paid for and arranged by the author; use of one of these services does not guarantee acceptance or preference for publication.
5.2. Units, Abbreviations and Nomenclature
All units of measurement must follow the SI system. Concentrations of solutions should be given as molar concentrations (e.g. mmol/L). All other concentrations should be expressed as percentages. Drug dosages should be given as: e.g. mg/kg; μg/kg; also use ‘once daily’, ‘twice daily’ etc. Spell out numbers one to nine, keep 10 onwards as numerals. However, use Arabic numerals for numbers used with units of measure (e.g. 9 kg, 5 h, 10 mmol/L). Use h, min, s, for hour, minute, second, respectively. Abbreviations of biological, medical, chemical and other terms should be used only when such abbreviations are both internationally recognized and unambiguous. The first use of an abbreviation must be explained by also giving the unabbreviated term.
All biological, medical, chemical and other names should be given in keeping with the latest international nomenclature. If an animal or micro-organism is being mentioned in the text for the first time, the binomial name should be given, e.g. carp (Cyprinus carpio). Thereafter, this can be abbreviated to C. carpio. Please check recent articles for information about the spelling of dog and cat breeds.
5.3. Figures (illustrations): Graphs, Tables, Clinical Photographs and Photomicrographs
Figure legends must be given at the end of the manuscript. Sufficient information should be included to allow the figure to be understood without reference to the text. Authors wishing to use any previously published figures must submit written permission from the copyright holder. Figure legends should be written in the following style:
1. Organ or tissue; animal identification, Case No. A sentence describing the change that is visible in the print. (For photomicrographs add: staining method with names of stains and counter stains and magnification, e.g. avidin–biotin– peroxidase complex method, Mayer's Haematoxylin counter stain, x40).
2. Graph or Table: statement of how data is expressed. Identification of symbols in table, graph, or photo: e.g. N, nucleus.
1. Photomicrograph: Intra-epidermal, intact sub-corneal pustule showing small numbers of acantholytic cells and numerous neutrophils. H&E.
2. Table: Comparison of eosinophil counts over time between the control and treatment groups. Error bars indicate the mean ± SD.
To ensure high-quality reproduction, symbols should be clear and even throughout and of sufficient size, that when reduced for publication, each item will still be legible. Graph axes should be labelled in sans serif (Helvetica or Arial) font. Letters, Numbers and Titles belong in the legends for illustrations, not on the illustrations themselves.
Software programmes such as GraphPad can be used to download graphs into a word document for submission as an image/figure file.
5.3.2. Tables should be limited to those containing data important to understanding and interpreting results and reducing or clarifying the text. Tables may be include within the word file containing the main text, placed after the figure legends; alternatively, large tables should be submitted as separate table files (e.g. in Word or Excel). Number tables consecutively in the order of the first citation in the text and supply a brief title for each. Give each column a short or abbreviated heading. Place explanatory material in footnotes, not in the heading. Explain in the footnotes all non-standard abbreviations that are used in each table. Identify statistical measures of variations such as standard deviation. Ensure that each table is cited in the text. If you use data from another published or unpublished source, obtain written permission and acknowledge fully.
5.3.3. Figures; Clinical Photographs & Photomicrographs (histopathology)
Such figures should be ideally be originally captured and submitted in a neutral data format such as TIFF or EPS. There is no requirement to convert an original uncompressed JPEG file to TIFF or EPS format. (JPEG format will be accommodated but must fulfil the format criteria given below and should be uncompressed). PowerPoint, PDFs and Word graphics are usually unsuitable for reproduction.
Figures should have a minimum resolution of 300 dpi; grey tone and line drawings require 600–1200 dpi. Photographic material should be of such quality that high-contrast that reproductions can be made. Poor-quality images may be removed from a manuscript and where critical to the content may lead to rejection of a manuscript.
Graphics created in the CMYK colour palette (print colours) are preferable to those created in RGB (screen colours) to maximize the consistency of print reproduction. Images supplied in RGB will be converted to CMYK for printing; this may lead to some variations in colour representation. Immunoflourescence images may be submitted in RGB.
When symbols, arrows, numbers or letters are used to identify parts of the illustrations, identify and explain each one clearly in the legend.
Clinical and histopathology (photomicrograph) figures must be no more than 19 cm in width and must be submitted at a resolution of 300 dpi.
Limit figures to those that reduce or clarify the text. These should be free of extraneous material and, where possible, if portions of the handler such as fingers or hands are to be included, particularly adjacent to lesions, they should be gloved.
Montage (composite plates) figures are allowed and should have no tooling (space bars) to separate the individual images. Each part should be labelled in the top left-hand corner in black, (or if appropriate for clarity in white) in Arial, in lower case, with no brackets, starting with a, b, c, etc.
The microscope must be set up for Koehler illumination, so that the light is evenly dispersed in the image.
The epidermis should be at the top of the image and horizontal; the background above the epidermis should be bright and white.
Authors are not obliged to use length or scale bars, reviewers/editors may recommend their use because it is deemed to be critical to the understanding of photomicrograph; they are required for electron micrograph images. Magnification (scale) bars should be black, approximately 1 cm long and placed in the lower right corner, 5 mm above the lower margin and with the right end 5 mm from the right margin.
For more information about the preparation of images please see the guidelines as attached here. While these guidelines were written some time ago and technology has moved on the general principles are still applicable. Please ensure that individual figures files are no larger than 5 MB. If your file is substantially bigger than this, please contact the Editorial Office: VDEedoffice@wiley.com; to discuss file saving and submission options.
5.4. References (Please note that EndNote™ and Refman™ software for the Journal of the American Veterinary Medical Association can be used for Veterinary Dermatology; please adapt to Vancouver style).
Software programs for creating reference lists may be used but they should be set up so that they generate in-text citations and reference lists according to the instructions and examples given below. Authors bear primary responsibility for the accuracy of all references. References must be limited to those that are necessary and must be cited in the text by superscript numbers in order of citation. Journal titles in the Reference section should be abbreviated in accordance with the National Library of Medicine (NLM website) and Index Medicus. For references with more than 3 authors, only the first 3 authors should be listed, followed by ‘et al.’ The following is the style used for common types of references:
Article in journal
1. Müntener T, Doherr MG, Guscetti F et al. The canine hair cycle – a guide for the assessment of morphological and immunohistochemical criteria. Vet Dermatol 2011; 22: 383-395.
2. Scott DW. Large Animal Dermatology. Philadelphia, PA: Saunders, 1988; 457–458.
3. Muir P, Johnson KA, Manley PA. Fractures of the pelvis. In: Birchard SJ, Sherding RG, eds. Saunders Manual of Small Animal Practice. 2nd edition. Philadelphia: W.B. Saunders Co., 2000; 1126–1132.
4. Kunkle G, Hillier A, Beale K et al. Steroid effects on intradermal skin testing in sensitized dogs. In: Proceedings of the American Academy of Veterinary Dermatology & American College of Veterinary Dermatology. Charleston, SC, USA: 1994; 54–55.
5. Animal and Plant Health Inspection Service website. Bovine spongiform encephalopathy (BSE). Available at: www.aphis.usda.gov/lpa/issues/bse/bse.html. Accessed Feb 18, 2003.
5.5. Supporting Information
Supporting information, such as data sets, additional figures, tables, video or audio files that will not be published in the print edition of the journal, but will be available via the online edition, may be submitted. Supporting information must be important ancillary information that is relevant to the parent article but which does not or cannot appear in the printed edition of the Journal. Supporting information will be published as submitted, and will not be corrected or checked for scientific content, typographical errors or functionality.
Supporting information should be uploaded at the time of manuscript submission using the file designation 'Supporting information'. It should be clearly stated at the time of submission that the Supporting Information is intended to be made available through the online edition. The content of the Supporting information must not be altered after the paper has been accepted for publication. Authors should note that the publishers will not be held responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) will be directed to the corresponding author of the article.
The availability of Supporting information should be indicated in the main manuscript by a paragraph, to appear after the References, headed "Supporting information" and providing titles of figures, tables etc. In order to protect reviewer anonymity, material posted on the author’s website cannot be reviewed.
5.6. Animal Experiments
Animal experiments are to be undertaken only with the purpose of advancing knowledge and in a manner that avoids unnecessary discomfort to the animals by the use of proper management and laboratory techniques. They shall be conducted in compliance with federal, state and local laws and regulations, and in accordance with the internationally accepted principles and guidelines for the care and use of agricultural, laboratory or experimental animals. In the interests of the reproducibility of results, accurate information about any test animals used in the experiments (origin, inbreeding etc.), as well as information about the housing conditions (diet, environment etc.), should be given. For further information and guidance on how to report on animal experiments see: ARRIVE guidelines for reporting animal research see: ARRIVE guidelines for reporting animal research
Upon acceptance of a paper for publication, the manuscript will be forwarded to the Production Editor who is responsible for the production of the journal.
6.1 Proof Corrections
The corresponding author will receive an e-mail alert containing a link to a website. A working e-mail address must therefore be provided for the corresponding author. The proof can be downloaded as a PDF (portable document format) file from this site; the file should be opened, read on screen, and printed out in order for any corrections to be added. Further instructions will be sent with the proof. Hard copy proofs will be posted if no e-mail address is available; in your absence, please arrange for a colleague to access your e-mail to retrieve the proofs. Proofs must be returned to the Production Editor within one week of receipt.
As changes to proofs are costly, we ask that you only correct typesetting errors. Other than in exceptional circumstances, all illustrations are retained by the publisher. Please note that the author is responsible for all statements made in their work, including changes made by the copy editor.
(Publication Prior to Print) Veterinary Dermatology is covered by Wiley-Blackwell's EarlyView service. EarlyView articles are complete full-text articles published online in advance of their publication in a printed issue. EarlyView articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of EarlyView articles means that they do not yet have volume, issue or page numbers, so EarlyView articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article.
6.3 Author Services
Online production tracking is available for your article through Wiley-Blackwell's Author Services. Author Services enables authors to track their article – once it has been accepted – through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit authorservices.wiley.com/bauthor/default.asp for more details about online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
Available to authors of primary research articles who wish to make their article available to non-subscribers upon publication in Veterinary Dermatology, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen the author, the author’s funding agency, or the author’s institution pays a fee (currently $3000) to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency’s preferred archive. In addition to publication online via Wiley Online Library, authors of OnlineOpen articles are permitted to post the final, published PDF of their article on a website, institutional repository or other free public server. For more information, please visit: http://olabout.wiley.com/WileyCDA/Section/id-406241.html. Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at: https://authorservices.wiley.com/bauthor/onlineopen_order.asp.
6.5 Author Material Archive Policy
Please note that unless specifically requested, Blackwell Publishing will dispose of all hard copy or electronic material submitted 2 months after publication. If you require the return of any material submitted, please inform the editorial office or production editor as soon as possible.
6.6 Offprints and Extra Copies
A PDF offprint of the online published article will be provided free of charge to the corresponding author, and may be distributed subject to the Publisher's terms and conditions. Additional paper offprints may be ordered online. Please click on the following link, fill in the necessary details and ensure that you type information in all of the required fields: offprint.cosprinters.com/cos/bw/main.jsp?SITE_ID=bw&FID=USER_HOME_PG.
If you have queries about offprints please e-mail: email@example.com.
6.7 Kudos: New Author Benefit to Increase Readership and Impact
Kudos is a web-based service that helps authors explain, enrich, and share their published work for greater readership and impact. It also provides direct access to a publication dashboard so authors can measure the effect of their actions across a wide range of metrics.
Wiley’s partnership with Kudos makes the service free for all Wiley authors. However, those who have registered with Wiley Author Services and opted into the mailing list will receive the most streamlined experience. The notification emails sent to those who are registered with Wiley Author Services contain a direct link to claim their article in Kudos. Authors who are unregistered or published prior to 2014 can claim authorship in Kudos by searching for articles by DOI, article title, or author name.
Once authors have claimed their articles, they are led through the following steps:
- Explain articles by adding lay summaries and highlighting what makes the work important.
- Enrich articles by adding links to related resources that put the research into context.
- Share via email and social media, while Kudos links across search engines and subject indexes.
- Access the dashboard area to view usage, citations, and altmetrics for the publications.
What are the benefits for authors?
- Discoverability and Impact – Increases the likelihood of their articles being found, read, and cited.
- Publication Metrics – Provides direct access to usage, citations, and altmetrics for their articles.
- Networking – Encourages interactions that build relationships and visibility within their communities.